Thus, experiments evaluating the functionality of these and other transcription factor-binding sites on the MALINC1 promoter are required to understand its regulation and the time points in tumor progression from DCIS to IBC in which it plays a role. This evidence concerns the gene MALINC1 and ductal breast carcinoma in situ.